No products in the cart.
Roll over image to zoom in
CELLCEPT 500MG TABLET
₹640.00₹773.00 (-17%)
Cellcept 500 mg tablet is an anti-inflammatory with an active ingredient dubbed Mycophenolate mofetil. It falls under the inosine monophosphate dehydrogenase (IMPDH) inhibitor class. The medicine is prescribed to avoid rejection of organs in patients who have received one of their organs (such as heart, kidney or even liver transplantation). It is prescribed as a part of a combination treatment, including other immunosuppressive medicines.
The use of this drug is not recommended during pregnancy because of the risk of miscarriage or congenital disabilities. It should not be used during pregnancy unless there are other alternatives and the advantages outweigh the risks. Women who are born should make use of effective contraception while using this tablet to avoid pregnancies. Live vaccines shouldn’t be administered when a person is taking the Cellcept 500mg tablet due to the decreased effectiveness of vaccines and the chance of getting ill. People taking this medication must not give blood during treatment and, at minimum, six weeks after having stopped treatment. This ensures that the drug is eliminated from the body before blood is donated.
It is recommended not to take this drug when allergic to the medication or other components. Inform your doctor about heart or liver problems before beginning treatment. Because this medication reduces the body’s immune defences, it could increase the risk of developing skin cancer. Patients must know how to minimize exposure to sun and UV (UV) ultraviolet (UV) light. Consult your physician immediately when you experience bruises on your face, fever, unprovoked fatigue, dizziness, eyes, or skin. Eyes vision impairment, decreased urinary output, or seizures following the use of this medication. Cellcept 500mg tablets are an anti-inflammatory medication. It could affect the infant’s developing immune system and should not be used when breastfeeding. In certain instances, alternatives to medications that have an improved safety profile when breastfeeding could be thought of as.